| Name | Author | |
|
With a steep growth in the economy, urbanization, and more affluent lifestyles for some, Western-type diseases have begun to emerge in India. The increasing prevalence of oncologic, cardiovascular, respiratory, and diabetic disorders, central nervous syst…
|
Anita Cooper, Corporate Senior Vice President and General Manager, Clinical Research Services, PAREXEL International |
|
Explosive development of new targeted therapy
for cancer and blood disease has generated
fierce competition for investigators and patients.
This causes serious problems for companies
trying to bring these innovations to market
in a timely and cost-effecti…
|
|
|
More than 1,200 patients were recruited at over 200 sites in 32 countries, 4 weeks ahead of schedule. This complex Phase III study of a first-line treatment for colorectal cancer required a global recruiting effort that included Europe, Latin America, Afr…
|
|
|
In the current competitive global market, you need uncomplicated access to a comprehensive breadth of services no matter your company size, global needs or therapeutic focus.
|
|
|
This global Phase IIIb study for breast cancer leveraged local cultural knowledge, efficient monitoring and strong site communications to exceed its challenging recruitment goals, enrolling over 4,000 patients across 20 countries in the Asia/Pacific, Nort…
|
|
|
Medical imaging in oncology trials is already well documented. Techniques such as CT, MRI and conventional radiology can provide insights into drug safety and efficacy faster than traditional clinical endpoints. Adopting an imaging strategy, however, int…
|
Gaurav Sawhney, Barbara Chandler, Kelie Williams, Sandra Chica, MD, Perceptive Informatics |